2023 Pilot and Feasibility Projects in Endocrinology & Diabetes
Pilot & Feasibility Program Director: Peter Tontonoz
As part of the mission of our UCSD/UCLA Diabetes Research Center (DRC) grant, the Pilot and Feasibility Grant Program will support grantees at approximately $40,000-50,000 direct costs (with additional ~55% indirect costs) in 2023. The maximum number of P&F awards an investigator may receive is two. Successful applicants can apply to have their first year of funding renewed for a second year by re-applying thefollowing year or may submit a second application in a subsequent year.
Applications DUE: April 3rd, 2023, to Dr. Peter Tontonoz at ptontonoz@mednet.ucla.edu
The DRC P&F mechanism will fund innovative new projects that will explore the feasibility of novel testable concepts and enhance the endocrine/diabetes research scope within the institutions. A special emphasis on promoting promising junior faculty involved with diabetes research is key to the UCSD/UCLA P&F mission. The DRC is also pleased to support clinical and/or translational research relevant to diabetes. The DRC strongly encourages submission of pilot and feasibility proposals in this area. It is expected that P&F studies will generate preliminary data that will be used by these investigators in diabetes/endocrinology-related R01 applications in the years following their award.